Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

Sigma-Aldrich and CPC Scientific Signs Distribution Agreement for Custom Peptide Libraries

Published: Friday, January 30, 2009
Last Updated: Monday, February 02, 2009
Bookmark and Share
CPC Scientific will offer Sigma-Aldrich's PEPscreen® custom peptide libraries to life science researchers across North America.

Sigma-Aldrich has announced that it has signed a distribution agreement with CPC Scientific. Under the terms of the agreement, CPC Scientific will offer Sigma-Aldrich's PEPscreen® custom peptide libraries to life science researchers and pharmaceutical companies in North America.

Sigma- Aldrich has developed a proprietary synthesis platform that enables the high throughput production of milligram quantities of peptides, which are ideal for producing custom peptide libraries applicable to peptide based drug discovery.

"In Sigma-Aldrich, we've found an experienced partner for the production of custom peptide libraries," said Dr. Shawn Lee, President & CEO of CPC Scientific. "The addition of PEPscreen custom peptide libraries to our portfolio benefits our customers by addressing the early research phase of peptide screening in the drug discovery workflow."

Sigma-Aldrich's peptide synthesis process significantly reduces the time required for peptide library development, reducing costs in the drug development process. The company's customized peptide libraries are utilized by the biotechnology industry to target active areas of small biological molecules with potential therapeutic properties.

"Our PEPscreen technology enables small scale, early stage drug candidate screenings," said Stacey Hoge, Senior Product Manager at Sigma-Aldrich. "CPC's close association with the pharmaceutical and biotechnology industry provides great opportunities for Sigma-Aldrich to further engage drug discovery researchers."

Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More Than 5,200+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

SAFC Completes Manufacturing Expansion in St. Louis
Expansion to support commercial-scale antibody drug conjugate (ADC) manufacturing.
Saturday, May 16, 2015
SAFC Expands Carlsbad, Calif. Facility
Expansion to support commercial-scale gene therapy production, testing and filling.
Saturday, May 16, 2015
Sigma-Aldrich Expands in Singapore
New State-of-the-Art Technical Center, cGMP Distribution Center and Headquarters enhances ability to support customers in the region.
Monday, April 20, 2015
Sigma-Aldrich & Roche Enter Exclusive Distribution Agreement
Provides researchers with global access to Roche biochemical reagents product portfolio.
Thursday, March 19, 2015
Sigma and Czech Center for Phenogenomics Collaborate
Sigma-Aldrich® and the Institute of Molecular Genetics, Czech Center for Phenogenomics, establish CRISPR core lab collaboration.
Friday, January 30, 2015
SAFC’s Dry Powder Media Manufacturing Facility in Irvine, Scotland
Officially opens following extensive validation process.
Friday, January 23, 2015
Sigma-Aldrich Licenses Foundational CRISPR Patents from Broad Institute
Company is able to make, use and distribute the advanced gene editing tools for numerous research applications.
Tuesday, December 09, 2014
Sigma-Aldrich to Restructure Business into Three New Units
Sigma-Aldrich has provided the first details of a major restructuring that will align its organisation into three customer and market-focused business units.
Thursday, November 22, 2012
SAGE® Labs, Ekam Imaging, Inc. Partner on Preclinical Imaging Assays
Companies to develop a suite of preclinical services based on the advanced translational power of genetically engineered rat models from SAGE Labs and Ekam's expertise in functional magnetic resonance imaging (fMRI) technology.
Friday, October 19, 2012
Sigma-Aldrich to Acquire BioReliance
Sigma-Aldrich Corporation has signed an agreement to acquire BioReliance Holdings, Inc. from Avista Capital Partners for $350 million in cash.
Tuesday, January 10, 2012
Biotech firm inks deal with Sigma-Aldrich
Henrietta-based biotechnology company Diffinity Genomics Inc. has inked a non-exclusive global distribution deal with Sigma-Aldrich Co. LLC, the local company said.
Wednesday, November 30, 2011
Hydrogen Storage Collaboration Between Sigma-Aldrich and Ilika Technologies to Scale-up and Commercialize Boron Hydride Materials
Materials show promise as high energy, low pressure hydrogen source.
Monday, July 25, 2011
Domainex Collaborates with Sigma-Aldrich to Advance the Study of Epigenetic Proteins Involved in Cancer and Stem Cell Biology
Domainex Ltd., have announced a collaboration with Sigma-Aldrich that will provide essential tools, including biochemical assays and monoclonal antibodies, for the study of proteins involved in the rapidly developing field of epigenetics.
Monday, November 15, 2010
Sigma® Life Science to Supply Oligonucleotides to Research Councils UK
A three-year contract with RCUK Shared Services Centre Limited to be a preferred supplier for synthetic oligonucleotides.
Monday, September 20, 2010
Sigma-Aldrich® Receives National Institutes of Health Funding for Cardiovascular Disease Research
Sigma® Life Science to analyze plasma samples from FHS in researching novel biomarkers for cardiovascular disease.
Monday, August 09, 2010
Scientific News
Unravelling the Role of Key Genes and DNA Methylation in Blood Cell Malignancies
Researchers from the University of Nebraska Medical Center have demonstrated the role of Dnmt3a in safeguarding normal haematopoiesis.
Salford Lung Study - The First Real World Clinical Trial
In this podcast, we learn about the Salford Lung Study and its potential to revolutionize the way we assess new drugs and treatments around the world.
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
Nanomedicine Aims to Improve HIV Drug Therapies
New research aims to improve the administration and availability of drug therapies to HIV patients using nanotechnology.
Tumor Markers Reveal Lethality Of Bladder Cancers
Researchers found that detection of certain tumor cells in early stage cancers helps identify high-risk cancers.
Gene Editing Corrects Sickle Cell Mutation
Researchers demonstrate a potential pathway to developing gene-editing treatments for sickle cell disease.
Driving Mosquito Evolution to Fight Malaria
Researchers propose insect repellent in conjunction with insecticides to extend current insecticide lifetime.
Lab-on-a-Chip to Help Detect Cancer
In this podcast, we speak to Gustavo Stolovitsky to learn about his career and the work he is doing at IBM Research.
ALS Study Reveals Role of RNA-Binding Proteins
The findings are a significant step forward in validating RNA-based therapy as a treatment for ALS.
Observing Direct Inheritance of Gene-Silencing RNA
Research has allowed for the observation of double-stranded RNA molecule being passed from parent to offspring in roundworms.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,200+ scientific videos